GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Science Inc (XKRX:343090) » Definitions » Research & Development

HLB Science (XKRX:343090) Research & Development : ₩ Mil (TTM As of . 20)


View and export this data going back to 2020. Start your Free Trial

What is HLB Science Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. HLB Science's Research & Development for the three months ended in . 20 was ₩0.00 Mil. HLB Science does not have enough years/quarters to calculate the Research & Development for the trailing twelve months (TTM) ended in . 20.


HLB Science Research & Development Historical Data

The historical data trend for HLB Science's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Science Research & Development Chart

HLB Science Annual Data
Trend Dec22 Dec23
Research & Development
2,147.59 963.45

HLB Science Quarterly Data
Research & Development

HLB Science Research & Development Calculation

This is the expense the company spent on research and development.


HLB Science  (XKRX:343090) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


HLB Science Research & Development Related Terms

Thank you for viewing the detailed overview of HLB Science's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


HLB Science (XKRX:343090) Business Description

Traded in Other Exchanges
N/A
Address
66, Achasan-ro, 6th Floor, Seongdong-gu, Seoul, KOR
HLB Science Inc develops biological new drugs to treat infectious diseases. Its product pipelines includes DD-S052P, DD-A279, and DD-A514.

HLB Science (XKRX:343090) Headlines

No Headlines